Symbol
LYEL on Nasdaq
Investment type
Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Ownership
1.04M shares
Security Ownership
5.6%

Gates Frontier, LLC ownership in Lyell Immunopharma, Inc. Common Stock, $0.0001 par value per share (LYEL)

2025-08-01 - Gates Frontier, LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.04M shares of Lyell Immunopharma, Inc. Common Stock, $0.0001 par value per share (LYEL). This represents 5.6% percent ownership of the company.